Globe Life (GL)
Sells basic life and supplemental health insurance through agency and direct-response channels.
Something off on this page? Send us feedback.
Sells basic life insurance and supplemental health coverage to lower-middle- and middle-income U.S. households through exclusive agents, independent agencies, and direct-response channels. Earnings come primarily from underwriting margins and investment income, with life insurance the largest margin contributor and agent recruiting central to agency growth.
Provides basic life insurance and supplemental health coverage, including Medicare Supplement, accident, cancer, and critical-illness policies, primarily to lower-middle- and middle-income households in the United States.
American Income Life, Liberty National, and Family Heritage distribute through exclusive independent agents; United American uses independent agencies, while Direct to Consumer markets through mail, digital media, and inbound phone channels. The mix combines local agency relationships with direct-response reach, and life insurance remains the largest source of underwriting margin.
Premiums and investment income fund policy benefits and operating costs, so results depend on underwriting assumptions, policy persistency, investment returns, and reserve adequacy. Agency growth depends on recruiting and retaining producing agents, and operations remain subject to state insurance regulation and exposure to agent-conduct and worker-classification claims.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Jul 15, 2026 | Piper Sandler | Reiterate | Rating: —Target: $175 | Target: $200 |
| Jul 10, 2026 | Jefferies | Reiterate | Rating: —Target: $90 | Target: $166 |
| May 26, 2026 | Piper Sandler | Reiterate | Rating: —Target: $167 | Target: $175 |
| May 21, 2026 | Morgan Stanley | Reiterate | Rating: —Target: $176 | Target: $181 |
| Apr 24, 2026 | Truist Financial | Target | Target: $158 | Target: $185 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $455.4M · Total debt $2.94B · Total assets $31.56B · Shareholders' equity $6.16B
- Revenue
- $1.60B
- Operating income
- −$629.6M
- Net income
- $287.7M
HistoryDividendAnnual yieldUpcoming
| Institutions | 85.45% | 65.66M shares | |
|---|---|---|---|
| 718 holders · as of Jun 30, 2026 | |||
| Insiders | 0.77% | 593.4K shares | |
| 24 holders · as of Aug 10, 2026 | |||
| Other | 13.78% | 10.59M shares | |
| remainder | |||
76.85M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 7.19% | 5.53M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 6.61% | 5.08M | as of Jun 30, 2026 |
Invesco Ltd.Institution | 6.01% | 4.62M | as of Jun 30, 2026 |
Vanguard Portfolio Management LLCInstitution | 5.44% | 4.18M | as of Jun 30, 2026 |
State Street CorpInstitution | 4.86% | 3.74M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 7, 2026 | Robert Brian Mitchell | officer: EVP, General Counsel and CRO | −23,000 | $183.34 |
| Jul 31, 2026 | James Matthew Darden | director, officer: Co-Chairman & CEO | −50,000 | $182.43 |
| Jul 29, 2026 | Michael Clay Majors | officer: EVP - Chief Strategy Officer | −37,000 | $178.64 |
| Jul 30, 2026 | Thomas Peter Kalmbach | officer: EVP & CFO | −21,000 | $180.06 |
| Jul 28, 2026 | Thomas Peter Kalmbach | officer: EVP & CFO | −25,650 | $178.58 |
- Primerica
Middle-income term life and agent distribution overlap
- CNO Financial Group
Middle-income life and supplemental health peer
- Aflac
Supplemental-health specialist with voluntary-benefits scale
- Unum Group
Workplace-benefits rival in life and supplemental coverage
- MetLife
Large group-benefits and life insurer with voluntary products
- Prudential Financial
Broad life and group-insurance competitor
- Lincoln Financial
Life and group-protection overlap, with supplemental health
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Globe Life | $169.40 | −1.60% | $13.37B | 11.4 | 10.2 | 2.2 | +8.0% |
| Primerica | $279.34 | −2.16% | $8.90B | 11.5 | 10.7 | 2.6 | +9.0% |
| CNO Financial Group | $53.25 | −2.11% | $5.08B | 18.6 | 11.2 | 1.1 | +11.6% |
| Aflac | $114.34 | −0.73% | $58.62B | 12.4 | 15.6 | 3.2 | −2.4% |
| Unum Group | $92.56 | −1.07% | $14.81B | 21.8 | 10.4 | 1.1 | −13.8% |
| MetLife | $95.45 | −1.23% | $62.18B | 18.5 | 9.1 | 0.8 | +10.0% |
| Prudential Financial | $116.74 | −1.51% | $41.13B | 10.7 | 8.3 | 0.6 | +2.8% |
| Lincoln Financial | $40.73 | −2.29% | $7.98B | 3.5 | 4.9 | 0.4 | +21.2% |
| Median | 12.4 | 10.4 | 1.1 | +9.0% |